Advancing Science Into Action: Enhancing PDMPs and EHRs
Date & Time
Wednesday, April 4, 2018, 9:45 AM - 11:00 AM
Stanley Murzynski, MS, Clinical Website Administrator, Illinois Prescription Monitoring Program
Lindsey Bridwell, MPH, CHES, Evaluation Fellow, Opioid Overdose Health Systems Team, Centers for Disease Control and Prevention
Joshua Vinciguerra, JD, Director of Bureau of Narcotic Enforcement, New York State Department of Health
Wesley M. Sargent, Jr., EdD, EdS, MA, Health Scientist, Centers for Disease Control and Prevention
Moderator: Jan Losby, PhD, MSW, Team Lead, Prescription Drug Overdose Health Systems Team, Centers for Disease Control and Prevention
CE Certified By: AMA,AAFP,ACPE,ANCC
Inappropriate prescribing is a key driver of the opioid crisis. To ensure the safer use of opioid therapy for patients, approaches for integrating prevention strategies into healthcare systems have been developed and implemented. In this session, speakers will highlight strategies used to operationalize the Centers for Disease Control and Prevention (CDC) Guideline for Prescribing Opioids for Chronic Pain recommendations into clinical practice through prescription drug monitoring programs (PDMPs). Reducing barriers to accessing PDMP data within clinical workflow, through PDMP-Electronic Health Record (EHR) integration is considered a promising state-level intervention for both informing clinical practice and improving patient care. CDC will share lessons learned from a nine-state evaluation on how PDMP-EHR integration promotes judicious opioid prescribing and facilitates communication between providers and patients about the risks and benefits of opioid therapy for chronic pain. Further, Illinois will highlight its new PDMP application, which calculates and reports patients’ current daily Morphine Milligram Equivalents (MMEs), within clinical workflow. This application uses color-coded MME numbers and trend graphs to alert prescribers when patients’ current daily MMEs are approaching a level that is associated with increased risks. Last, New York will discuss enhancements of its PDMP, including mandated use (requirements for initial and subsequent PDMP checks for controlled substances) and timely submission of data.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Describe how PDMP integration with electronic health records promotes judicious prescribing and improves patient outcomes.
- Identify health information technology strategies that support operationalization of the Centers for Disease Control and Prevention Prescribing Guideline.
- Explain how applications within the PDMP and/or EHR can support clinical decision-making.